Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775565 · ClinicalTrials.gov registry record
Initial Experience With the AngioVac Venous Drainage Cannula
A clinical trial of Heart Disease, sponsored by Angiodynamics.
- Completed
- Registry status
- 51
- Enrollment target
- 5
- Study locations
NCT02775565: Completed study of Heart Disease, sponsored by Angiodynamics.
NCT02775565 is a study of Heart Disease that has completed, run by Angiodynamics. The registered enrollment target is 51 participants, below the 2,045-participant average among 31 other Heart Disease trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02775565, a study of Heart Disease, has completed, sponsored by Angiodynamics.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.
Conditions Studied
Interventions
- DEVICE AngioVac
Study Locations (5)
California
- Providence St. Joseph - Burbank
- UCLA - Los Angeles
North Dakota
- Sanford Research - Fargo
South Carolina
- MUSC - Charleston
Washington
- Swedish Health Services - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-05 |
What the finished NCT02775565 record still lists
NCT02775565 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 2,045-participant average among 31 other Heart Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which AngioVac is the first listed.
NCT02775565 lists 5 locations in 4 states (California, North Dakota, South Carolina).
Frequently Asked Questions
What is clinical trial NCT02775565 about?
NCT02775565 is a clinical study titled "Initial Experience With the AngioVac Venous Drainage Cannula". This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must me...
What is the current status of trial NCT02775565?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2016-02. Estimated completion is 2017-05.
What conditions does trial NCT02775565 study?
This clinical trial studies the following conditions: Heart Disease.
What interventions are being tested in trial NCT02775565?
The interventions under investigation include: AngioVac (DEVICE).
Who is sponsoring clinical trial NCT02775565?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02775565 being conducted?
This trial has 5 study locations across California, North Dakota, South Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02775565's enrollment target sits among peer trials
51 27th of 31 higher than 5 of 31 other Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions
RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
-
Personalized Environment and Genes Study
RECRUITING
-
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
RECRUITING · NA
-
Heart Disease of the Small Arteries in Women and Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia